Rate My Professor Tapio Visakorpi

Visakorpi's research focuses on the molecular mechanisms of prostate cancer, including androgen receptor signaling, gene amplifications and fusions, non-coding RNAs, RNA-binding proteins, and interactions between cancer cells and the tumor microenvironment such as immunosuppressive myeloid cells. His seminal contributions include the discovery of in vivo amplification of the androgen receptor gene in progressing human prostate cancer (Visakorpi et al., 1995), microRNA expression profiling in prostate cancer (Porkka et al., 2007), and identification of TMPRSS2:ERG fusion as a subgroup marker (Saramäki et al., 2008). Recent publications encompass disruption of androgen receptor-cofactor interactions by FUS/TLS (Brooke et al., 2026), protein-coding genes associated with metastatic prostate cancer (Sattari et al., 2025), and single-cell transcriptomics highlighting club-like cell interactions with myeloid cells (Kiviaho et al., 2024). With 294 research outputs, he has served on 10 editorial boards, supervised doctoral candidates, acted as opponent in 12 dissertations, and held 46 positions of trust in funding organizations alongside 37 in academic communities. Visakorpi has been a member of the Finnish Academy of Science and Letters since 2007.